ProCE Banner Activity

HER2 Assessment and Testing in 2025: What HCPs Need to Know

Slideset

Download these slides from an ASCO 2025 live satellite symposium on assessing for HER2-low or ultralow status in patients with metastatic breast cancer based on the latest clinical guidelines and expert recommended best practices.

Released: May 23, 2025

Expiration: November 22, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.